Published in Immunobiology on November 01, 1993
Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest (1998) 5.70
Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J Clin Invest (1994) 2.57
Influenza virus neuraminidase activates latent transforming growth factor beta. J Virol (1996) 2.17
Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice. J Virol (2010) 1.63
IL-1 produced and released endogenously within human islets inhibits beta cell function. J Clin Invest (1998) 1.46
Involvement of the mannose receptor in infection of macrophages by influenza virus. J Virol (2000) 1.45
Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses. J Virol (2011) 1.40
Role of interleukin-12 in primary influenza virus infection. J Virol (1998) 1.30
Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry. J Virol (2010) 1.16
Mechanisms of virus induced exacerbations of asthma. Thorax (1997) 1.12
DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation during influenza A virus infection: role of DDX21-TRIF-TLR4-MyD88 pathway. PLoS Pathog (2014) 1.05
DAS181, a sialidase fusion protein, protects human airway epithelium against influenza virus infection: an in vitro pharmacodynamic analysis. J Antimicrob Chemother (2009) 1.04
Innate immunity to H5N1 influenza viruses in humans. Viruses (2012) 0.94
Phenotypic differences in virulence and immune response in closely related clinical isolates of influenza A 2009 H1N1 pandemic viruses in mice. PLoS One (2013) 0.88
Viral pathogens and acute lung injury: investigations inspired by the SARS epidemic and the 2009 H1N1 influenza pandemic. Semin Respir Crit Care Med (2013) 0.81
Interleukin-1 beta and neurotrophin-3 synergistically promote neurite growth in vitro. J Neuroinflammation (2011) 0.81
Histopathological evaluation of the diversity of cells susceptible to H5N1 virulent avian influenza virus. Am J Pathol (2013) 0.81
HIV-1 and its gp120 inhibits the influenza A(H1N1)pdm09 life cycle in an IFITM3-dependent fashion. PLoS One (2014) 0.78
Autophagy, TGF-β, and SMAD-2/3 Signaling Regulates Interferon-β Response in Respiratory Syncytial Virus Infected Macrophages. Front Cell Infect Microbiol (2016) 0.76
Antiviral activity of chlorogenic acid against influenza A (H1N1/H3N2) virus and its inhibition of neuraminidase. Sci Rep (2017) 0.75
Increased Survivorship and Altered Cytokine Profile from Treatment of Influenza A H1N1-Infected Mice with Ekybion: A Drug Complex of Natural Extracts and Inorganic Compounds. Evid Based Complement Alternat Med (2010) 0.75
Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam2Cys. Immunol Cell Biol (2015) 0.75
Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med (1999) 4.20
An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A (1996) 3.79
MAT alpha 1 protein, a yeast transcription activator, binds synergistically with a second protein to a set of cell-type-specific genes. Cell (1987) 3.74
Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J Immunol (1982) 3.24
A yeast gene (BEM1) necessary for cell polarization whose product contains two SH3 domains. Nature (1992) 3.20
Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods (1999) 3.09
Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology (2000) 2.65
Control of the yeast bud-site assembly GTPase Cdc42. Catalysis of guanine nucleotide exchange by Cdc24 and stimulation of GTPase activity by Bem3. J Biol Chem (1994) 2.63
Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol (1988) 2.58
Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J Clin Invest (1994) 2.57
A large fraction of human peripheral blood gamma/delta + T cells is activated by Mycobacterium tuberculosis but not by its 65-kD heat shock protein. J Exp Med (1990) 2.37
The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A (1997) 2.36
Interactions between the bud emergence proteins Bem1p and Bem2p and Rho-type GTPases in yeast. J Cell Biol (1994) 2.29
Acetic acid-guided biopsies after magnifying endoscopy compared with random biopsies in the detection of Barrett's esophagus: a prospective randomized trial with crossover design. Gastrointest Endosc (2006) 2.28
Yeast peptide pheromones, a-factor and alpha-factor, activate a common response mechanism in their target cells. Cell (1986) 2.26
Interactions among proteins involved in bud-site selection and bud-site assembly in Saccharomyces cerevisiae. J Biol Chem (1995) 2.20
Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med (1998) 2.11
Loading of the knee joint during activities of daily living measured in vivo in five subjects. J Biomech (2010) 2.03
Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol (1997) 2.00
Programmed cell death (apoptosis) in human monocytes infected by influenza A virus. Immunobiology (1994) 1.98
The primary response of human gamma/delta + T cells to Mycobacterium tuberculosis is restricted to V gamma 9-bearing cells. J Exp Med (1991) 1.69
RSR1, a ras-like gene homologous to Krev-1 (smg21A/rap1A): role in the development of cell polarity and interactions with the Ras pathway in Saccharomyces cerevisiae. Mol Cell Biol (1992) 1.64
Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha. J Immunol (1988) 1.53
Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running. Clin Immunol Immunopathol (1992) 1.51
Kinetics of the transformation of Gram-negative rods to spheroplasts and ghosts by serum. J Immunol (1966) 1.51
Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response. J Leukoc Biol (1997) 1.51
Associations among PH and SH3 domain-containing proteins and Rho-type GTPases in Yeast. J Cell Biol (1996) 1.46
T cell receptor/CD3-signaling induces death by apoptosis in human T cell receptor gamma delta + T cells. J Immunol (1991) 1.45
Diversity of the anti-T-cell receptor immune response and its implications for T-cell vaccination therapy of multiple sclerosis. Brain (1998) 1.41
Transvenous occlusion of dural cavernous sinus fistulas through the thrombosed inferior petrosal sinus: report of four cases and review of the literature. Surg Neurol (2000) 1.41
Influenza A virus infection of macrophages. Enhanced tumor necrosis factor-alpha (TNF-alpha) gene expression and lipopolysaccharide-triggered TNF-alpha release. J Immunol (1991) 1.39
Atypical stiff-person syndrome with spinal MRI findings, amphiphysin autoantibodies, and immunosuppression. Neurology (1998) 1.39
Tumor necrosis factor-alpha production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides. J Immunol (1990) 1.36
Biochemical comparisons of the Saccharomyces cerevisiae Bem2 and Bem3 proteins. Delineation of a limit Cdc42 GTPase-activating protein domain. J Biol Chem (1993) 1.34
Interleukin 1 and the glomerular mesangium. I. Purification and characterization of a mesangial cell-derived autogrowth factor. J Immunol (1986) 1.34
Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells. J Immunol (2000) 1.32
Chemokines in the cerebrospinal fluid of patients with meningitis. Clin Immunol Immunopathol (1996) 1.31
Sensitivity enhancement in pulse EPR distance measurements. J Magn Reson (2004) 1.31
Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages. J Leukoc Biol (2001) 1.30
Activation of glomerular mesangial cells by the terminal membrane attack complex of complement. J Immunol (1987) 1.30
Coxsackievirus B3-induced production of tumor necrosis factor-alpha, IL-1 beta, and IL-6 in human monocytes. J Immunol (1992) 1.25
Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest (1996) 1.24
Macrophages release arachidonic acid, prostaglandin E2, and thromboxane in response to late complement components. J Immunol (1984) 1.24
Prostaglandin synthesis in spleen cell cultures of mice injected with Corynebacterium parvum. Cell Immunol (1978) 1.20
Isolated cysticercosis of the breast masquerading as a breast tumour: report of a case and review of literature. Ann Trop Med Parasitol (2011) 1.20
Realistic loads for testing hip implants. Biomed Mater Eng (2010) 1.19
Aggressive confusional state as a clinical manifestation of status epilepticus in MELAS. Neurology (2003) 1.18
Characterization of blood mononuclear cells of rheumatoid arthritis patients. I. Depressed lymphocyte proliferation and enhanced prostanoid release from monocytes. Clin Immunol Immunopathol (1982) 1.18
The effects of phagocytosis, dextran sulfate, and cell damage on PGE1 sensitivity and PGE1 production of macrophages. J Immunol (1978) 1.17
Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection. J Exp Med (1996) 1.17
Activation and activation-driven death of human gamma/delta T cells. Immunol Rev (1991) 1.16
Control of yeast alpha-specific genes: evidence for two blocks to expression in MATa/MAT alpha diploids. Proc Natl Acad Sci U S A (1985) 1.15
Infection of macrophages by influenza A virus: characteristics of tumour necrosis factor-alpha (TNF alpha) gene expression. Res Virol (1997) 1.15
Interactions between the ankyrin repeat-containing protein Akr1p and the pheromone response pathway in Saccharomyces cerevisiae. Mol Cell Biol (1996) 1.15
Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2. J Immunol (1989) 1.13
Macrophage cytotoxicity: interleukin 1 as a mediator of tumor cytostasis. J Immunol (1986) 1.13
Differential mononuclear leukocyte attracting chemokine production after stimulation with active and inactivated influenza A virus. Cell Immunol (1998) 1.11
MIF expression in the rat brain: implications for neuronal function. Mol Med (1998) 1.10
Carotenoid binding sites in LHCIIb. Relative affinities towards major xanthophylls of higher plants. Eur J Biochem (2000) 1.10
Changes in cognitive function after neuronal cell transplantation for basal ganglia stroke. Neurology (2004) 1.08
Defense against influenza A virus infection: essential role of the chemokine system. Immunobiology (2001) 1.07
Induction of cytokines and chemokines in human monocytes by Mycoplasma fermentans-derived lipoprotein MALP-2. Infect Immun (1999) 1.07
Macrophage-activating factors from different T cell clones induce distinct macrophage functions. J Immunol (1983) 1.06
Release of cyclic AMP from macrophages by stimulation with prostaglandins. J Immunol (1975) 1.06
Design and calibration of load sensing orthopaedic implants. J Biomech Eng (2008) 1.05
Treatment of a cavernous sinus dural arteriovenous fistula by deep orbital puncture of the superior ophthalmic vein. Neuroradiology (2001) 1.04
Identification of the bud emergence gene BEM4 and its interactions with rho-type GTPases in Saccharomyces cerevisiae. Mol Cell Biol (1996) 1.04
Enhancement of glomerular mesangial cell neutral proteinase secretion by macrophages: role of interleukin 1. J Immunol (1986) 1.04
Control of prostanoid synthesis: role of reincorporation of released precursor fatty acids. Prostaglandins (1986) 1.03
Drugs which disrupt microtubules do not inhibit the initiation of lymphocyte activation. Nature (1977) 1.01
Lysozyme and serum bactericidal action. Nature (1966) 1.01
In vivo glenohumeral contact forces--measurements in the first patient 7 months postoperatively. J Biomech (2006) 0.99
Meat and meat products in human nutrition in developing countries. FAO Food Nutr Pap (1992) 0.99
Paradoxical air embolism from a central venous catheter. Br J Anaesth (2009) 0.98
Long-term outcome in patients with Guillain-Barré syndrome requiring mechanical ventilation. J Neurol (2013) 0.97
Low prevalence of the immunoglobulin-A-binding beta antigen of the C protein among Streptococcus agalactiae isolates causing neonatal sepsis. Eur J Clin Microbiol Infect Dis (1999) 0.97
Systemic macrophage stimulation in rats with silicosis: enhanced release of tumor necrosis factor-alpha from alveolar and peritoneal macrophages. Am J Respir Cell Mol Biol (1991) 0.97
Immune-interferon (IFN-gamma), macrophage-activating factors (MAFs), and colony-stimulating factors (CSFs) secreted by T cell clones in limiting dilution microcultures, long-term cultures, and by T cell hybridomas. Immunol Rev (1983) 0.97
Characterization of a high molecular weight tumor necrosis factor-alpha mRNA in influenza A virus-infected macrophages. J Immunol (1994) 0.95
Induction of prostaglandin E release from macrophages by colchicine. J Immunol (1980) 0.95
Membrane perturbation and stimulation of arachidonic acid metabolism. Mol Immunol (1982) 0.95
Activation of macrophages by lymphokines from T-cell clones: evidence for different macrophage-activating factors. Mol Immunol (1984) 0.94
Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization. Biochim Biophys Acta (1988) 0.93
Enhancement of the PGE1 response of macrophages by concanavalin A and colchicine. J Immunol (1977) 0.93
Time course of chemokines in the cerebrospinal fluid and serum during herpes simplex type 1 encephalitis. J Neurol Sci (1998) 0.93